The titanium device, first dreamt up by Daniel Timms and his father, could replace traditional organ transplants altogether ...

However, we are encouraged by our past successes with innovative companies like Vaxxas and BiVACOR, and we remain highly optimistic about the significant opportunities within the healthcare sector ...

On March 6, he underwent a successful donor heart transplant after relying on the BiVACOR Total Artificial Heart for 105 days. The patient, who wishes to remain anonymous, had severe end-stage ...

State of the City report underscores the city’s transformation into a launchpad for successful emerging businesses generating ...

The global Heart Pump Device Market is expected to rise from USD 4.0 billion in 2024 to USD 25.4 billion by 2034. By 2034, the market is projected to surge at 20.4% CAGR. The global Heart Pump Device ...